Legislature(2021 - 2022)DAVIS 106
04/22/2021 03:00 PM House HEALTH & SOCIAL SERVICES
Note: the audio
and video
recordings are distinct records and are obtained from different sources. As such there may be key differences between the two. The audio recordings are captured by our records offices as the official record of the meeting and will have more accurate timestamps. Use the icons to switch between them.
| Audio | Topic |
|---|---|
| Start | |
| HB133 | |
| HB145 | |
| HB106 | |
| HB184 | |
| Adjourn |
* first hearing in first committee of referral
+ teleconferenced
= bill was previously heard/scheduled
+ teleconferenced
= bill was previously heard/scheduled
| += | HB 133 | TELECONFERENCED | |
| + | HB 106 | TELECONFERENCED | |
| *+ | HB 184 | TELECONFERENCED | |
| + | TELECONFERENCED | ||
| += | HB 145 | TELECONFERENCED | |
HB 145-EXPAND PHARMACIST AUTHORITY
3:30:15 PM
CO-CHAIR ZULKOSKY announced that the next order of business
would be HOUSE BILL NO. 145, "An Act relating to the Board of
Pharmacy; relating to health care services provided by
pharmacists and pharmacy technicians; and relating to the
practice of pharmacy."
3:30:56 PM
REPRESENTATIVE SPOHNHOLZ moved to adopt Amendment 1 to HB 145,
labeled 32-LS0720\A.1, Fisher, 4/19/21, which read as follows:
Page 5, following line 18:
Insert a new bill section to read:
"* Sec. 12. AS 21.42 is amended by adding a new
section to read:
Sec. 21.42.440. Coverage for costs of services
provided by pharmacists. A policy, contract, or
prepaid plan for individual or group health insurance
issued or delivered in the state that provides
coverage for services within the scope of practice of
a pharmacist licensed under AS 08.80 must provide for
coverage of and reimbursement for the services if
performed by a pharmacist for a person covered under
the policy, contract, or plan."
3:30:58 PM
CO-CHAIR ZULKOSKY objected for discussion purposes.
3:31:01 PM
REPRESENTATIVE SPOHNHOLZ explained that the purpose of Amendment
1 would be to require insurance to cover services that
pharmacists are trained to provide, but for which pharmacists
are not currently able to receive reimbursement. She said that
this would help provide health care in the community.
3:31:40 PM
CO-CHAIR SNYDER commented that the amendment would add language
to the bill that would further ensure that pharmacists could be
reimbursed for the services provided.
3:32:10 PM
CO-CHAIR ZULKOSKY removed her objection. There being no further
objection, Amendment 1 was adopted.
3:32:22 PM
REPRESENTATIVE MCCARTY moved to adopt Amendment 2 to HB 145,
labeled 32-LS0720\A.2, Fisher, 4/19/21, which read:
Page 4, following line 12:
Insert a new subsection to read:
"(c) This section does not authorize a
pharmacist to prescribe a prescription drug that the
pharmacist is not otherwise authorized to prescribe."
Reletter the following subsection accordingly.
3:32:27 PM
CO-CHAIR ZULKOSKY objected for discussion purposes.
3:32:31 PM
REPRESENTATIVE MCCARTY explained that Amendment 2 would insert a
new section that would recognize the authorization of a
pharmacist under the guidelines of the scope of practice for
pharmacy. It would ensure that pharmacists would not be able to
prescribe beyond the scope of practice, he added.
3:33:06 PM
REPRESENTATIVE KURKA shared his understanding that, when a
doctor prescribes a new medication, the doctor looks at all the
other medications the patient might be taking to ensure that the
medications will not react poorly with each other. He asked
whether prescribing pharmacists would have access to the same
information to ensure that there would be no negative reactions
with a patient's other medications.
CO-CHAIR SNYDER responded that Amendment 2 aims to further
narrow the scope of pharmacists, which may address
Representative Kurka's concern, and deferred the question to
invited testifiers.
3:34:31 PM
TOM WADSWORTH, PharmD, Administrative Director, University of
Alaska/Idaho State University Doctor of Pharmacy Program,
responded absolutely, and explained that pharmacists have a
patient care process that is similar to all patient care
processes. He said that it includes collaboration with
documentation, which includes collecting Electronic Medical
Records (EMR), paper records, referrals, laboratory studies,
past medical histories, and histories of the chief complaint of
the patient. He explained that pharmacists have access to all
this information, and if for some reason that information is
missing, pharmacists either order or ask for the information.
He opined that it would be unprofessional for a pharmacist to
proceed without proper access to that information.
MR. WADSWORTH referenced Section 8 of HB 145, which discusses
the collaborative authority of pharmacists, and said that the
collaborative practice agreements that pharmacists already have
with physicians involve drawing up specific protocols and
procedures in the patient care process that the pharmacist and
the collaborating provider will adhere to. He explained that
those protocols and procedures are reviewed by the Board of
Pharmacy and the Board of Medicine in Alaska before they can be
implemented. He said that these precautions prevent pharmacists
from going outside of their area of expertise or scope of
practice.
3:38:32 PM
JUSTIN RUFFRIDGE, PharmD, State Board of Pharmacy, added that
the information flow between pharmacists and providers goes both
directions. Pharmacists, he said, access medical histories of
patients to ascertain if there may be any medication conflicts
or other potential issues. He explained that many pharmacies
keep and use those records if a patient transfers to a different
prescriber or goes into the hospital. Pharmacists are involved
in reviewing patient charts with the intake nurse if a patient
were to enter a hospital or intake facility, he said.
3:40:04 PM
The committee took an at-ease from 3:40 p.m. to 3:41 p.m.
3:41:38 PM
CO-CHAIR ZULKOSKY removed her objection. There being no further
objection, Amendment 2 was adopted.
3:41:56 PM
CO-CHAIR SNYDER said she sees the need for legislation that
would ensure that the Board of Pharmacy can oversee pharmacists,
and that pharmacists can be reimbursed for the services
provided. She also emphasized the need for clarity to ensure
that pharmacists' scope of practice is not being expanded by the
proposed legislation. She said she would offer a conceptual
amendment to accomplish this.
3:43:58 PM
CO-CHAIR SNYDER moved to adopt Conceptual Amendment 3 to HB 144,
as follows [original punctuation provided]:
Page 4, Line 1:
Delete "for a disease or condition with an
existing diagnosis and for a condition that does not
require a new diagnosis."
Page 4, Line 5:
Delete "and
Insert "or"
Page 4, Line 6:
Delete "optimization of medication therapy for"
REPRESENTATIVE FIELDS objected for discussion purposes.
CO-CHAIR SNYDER explained her conceptual amendment would further
clarify that the bill would not interfere with the collaborative
practice authority (CPA) regulation and would remove language so
as not to imply an expansion of pharmacists' prescribing
authority.
3:45:30 PM
MR. WADSWORTH expressed his support for Conceptual Amendment 3.
He explained that, in working with the Alaska State Medical
Association, he realized the language that was chosen in the
bill sought to modify the CPA regulation that's been in place
since 2002. He said that the intent is not to modify or change
that process as it already works well in its current state. He
shared his understanding that other language in the bill seemed
to broaden independent prescriptive authority for pharmacists,
and Conceptual Amendment 3 would clarify the intent of the bill
and ensure that prescriptive authority would not be broadened.
3:47:02 PM
REPRESENTATIVE MCCARTY asked whether there would be a need for a
period after "services" in Section 8 of HB 145, on page 4, line
1, ["provide patient care services"], given that Conceptual
Amendment 3 proposes the deletion language on page 4, line 1,
[text provided previously].
CO-CHAIR ZULKOSKY responded that when a motion comes before the
committee, there will likely be a recommendation to make
technical and conforming changes as needed. She said those
changes would be made by Legislative Legal Services.
CO-CHAIR SNYDER commented that she would request that
Legislative Legal Services add a period as it is needed.
3:47:59 PM
REPRESENTATIVE KURKA asked for clarification of the changes
being made by the amendment, and whether it would widen the
scope of pharmacists.
CO-CHAIR SNYDER responded that the first part of Conceptual
Amendment 3, which proposes the deletion of language on page 4,
line 1, would make HB 145 consistent with the CPA. She
explained that it is not about widening or narrowing the scope
of pharmacists, but simply making it consistent with existing
CPA regulations. She added that the second component of the
conceptual amendment would further clarify that the scope of
services that pharmacists can provide is not being broadened.
3:49:43 PM
REPRESENTATIVE FIELDS removed his objection. There being no
further objection, Conceptual Amendment 3 was adopted.
3:49:55 PM
REPRESENTATIVE KURKA shared his understanding that the bills
main purpose is to expand the ability of pharmacists to help
consult patients and administer tests, particularly COVID-19
tests. He asked to what extent the scope of pharmacists would
be increased or not increased should HB 145 pass.
CO-CHAIR SNYDER answered that the intent is to provide
clarification on the range of practices that pharmacists are
already engaged in to ensure that "out of date" statutes reflect
the current state of practice. She mentioned testing,
vaccination, and administration of Naloxone as additional
details that needed to be captured. She explained that the
final intent of the bill is that pharmacists have already been
providing this type of care for an extended period of time, but
pharmacists were not able to be reimbursed by insurance due to a
lack of language [in statute].
3:52:12 PM
MR. RUFFRIDGE added that the Board of Pharmacy is attempting to
regulate the areas in which pharmacists are engaged, ensure that
pharmacists are seen as practicing within their scope, and
pharmacists are able to be reimbursed for their practices. He
emphasized that pharmacists both dispense medications and act as
a "middle manager" in health care. He said that pharmacists
rarely find themselves in entities such as hospitals where
insurances can be billed for the services that pharmacists
provide. He said the conceptual amendment wouldn't change the
ways in which pharmacists dispense medications but would remove
limitations to ensure that pharmacists are able to perform fully
as a "manager of care in the middle." He offered clarification
that pharmacists are providers of services, not just dispensers,
and said that the proposed legislation with the conceptual
amendment would allow for that.
3:54:42 PM
REPRESENTATIVE MCCARTY requested clarification on the potential
for pharmacists to offer treatment through the dispensing of
Buprenorphine.
MR. RUFFRIDGE responded that work needs to be done nationwide on
this issue. He noted that there are other requirements to be a
part of a medication-assisted treatment (MAT) program, one of
which is a federal change that would have to happen. He said
that pharmacists are already engaged in this in primary care
settings. As far as a wider offering [of the medication] that
Representative McCarty is suggesting, HB 145 is a step in that
direction, he said. He explained that the bill would well-
position the state to be available to implement those additional
types of therapies should the federal changes be made.
REPRESENTATIVE MCCARTY commented that he hopes the state stays
within the guidelines of the Substance Abuse and Mental Health
Services Administration (SAMHSA) and the MAT program.
3:57:51 PM
REPRESENTATIVE FIELDS moved to report HB 145, as amended, out of
committee with individual recommendations and the accompanying
fiscal notes. There being no objection, CSHB 145(HSS) was
reported from the House Health and Social Services Standing
Committee.
| Document Name | Date/Time | Subjects |
|---|---|---|
| 10 CSHB 133 Fiscal Note UA-SYSBRA 3.13.21.pdf |
HHSS 4/22/2021 3:00:00 PM |
HB 133 |
| 1 CSHB 133 ver I Sponsor Statement 4.8.2021.pdf |
HHSS 4/22/2021 3:00:00 PM |
HB 133 |
| HB 133 Sponsor Presentation 3.30.21.pdf |
HHSS 4/22/2021 3:00:00 PM |
HB 133 |
| 2 CSHB0133 ver I.PDF |
HHSS 4/22/2021 3:00:00 PM |
HB 133 |
| 3 CSHB 133 Summary of Changes ver B to ver I 4.8.2021.pdf |
HHSS 4/22/2021 3:00:00 PM |
HB 133 |
| 4 Sectional Analysis CSHB 133 ver I 4.8.2021.pdf |
HHSS 4/22/2021 3:00:00 PM |
HB 133 |
| 5 HB0133 ver B.PDF |
HHSS 4/22/2021 3:00:00 PM |
HB 133 |
| 6 CSHB 133 Supporting Document - IRS ABLE Accounts Info 3.18.21.pdf |
HHSS 4/22/2021 3:00:00 PM |
HB 133 |
| 7 CSHB 133 Supporting Document - 10 Things You Should Know About ABLE 3.18.21.pdf |
HHSS 4/22/2021 3:00:00 PM |
HB 133 |
| 8 CSHB 133 Supporting Document - UA Press Release 3.18.21.pdf |
HHSS 4/22/2021 3:00:00 PM |
HB 133 |
| 9 CSHB 133 Fiscal Note DHSS, 3.18.21.pdf |
HHSS 4/22/2021 3:00:00 PM |
HB 133 |
| HB 145 DCCED Letter 4.14.21.pdf |
HHSS 4/22/2021 3:00:00 PM |
HB 145 |
| HB 145 Fiscal Note - DCCED, 4.09.21.pdf |
HHSS 4/22/2021 3:00:00 PM |
HB 145 |
| HB0145A.PDF |
HHSS 4/22/2021 3:00:00 PM |
HB 145 |
| HB 145, AK Pharmacists Assn. Fact Sheet.pdf |
HHSS 4/22/2021 3:00:00 PM |
HB 145 |
| HB 145, AK Pharmacists Assn. Talking Points.pdf |
HHSS 4/22/2021 3:00:00 PM |
HB 145 |
| HB 145, Sectional Analysis, Ver. A.pdf |
HHSS 4/22/2021 3:00:00 PM |
HB 145 |
| HB 145 LOS since 4.16.21.pdf |
HHSS 4/22/2021 3:00:00 PM |
HB 145 |
| HB 145, Sponsor Statement, Ver. A.pdf |
HHSS 4/22/2021 3:00:00 PM |
HB 145 |
| HB 106 Sectional Analysis 04.12.2021.pdf |
HHSS 4/22/2021 3:00:00 PM HHSS 5/13/2021 3:00:00 PM |
HB 106 |
| HB 106 Sponsor Statement 04.12.2021.pdf |
HHSS 4/22/2021 3:00:00 PM HHSS 5/13/2021 3:00:00 PM |
HB 106 |
| HB0106A.PDF |
HHSS 4/22/2021 3:00:00 PM |
HB 106 |
| HB 106 Additional Statistics 04.12.2021.pdf |
HHSS 4/22/2021 3:00:00 PM |
HB 106 |
| HB 106 DPS Fiscal Note 04.12.2021.pdf |
HHSS 4/22/2021 3:00:00 PM HHSS 5/13/2021 3:00:00 PM |
HB 106 |
| HB 106 HSS Fiscal Note 04.12.2021.pdf |
HHSS 4/22/2021 3:00:00 PM HHSS 5/13/2021 3:00:00 PM |
HB 106 |
| HB0184A.PDF |
HHSS 4/22/2021 3:00:00 PM HTRB 5/4/2021 8:00:00 AM |
HB 184 |
| HB 184 Sectional Analysis version A.pdf |
HHSS 4/22/2021 3:00:00 PM HTRB 5/4/2021 8:00:00 AM SHSS 3/31/2022 1:30:00 PM |
HB 184 |
| HB 184 Sponsor Statement version A.pdf |
HHSS 4/22/2021 3:00:00 PM HTRB 5/4/2021 8:00:00 AM SHSS 3/31/2022 1:30:00 PM |
HB 184 |
| HB 145 Amendments.pdf |
HHSS 4/22/2021 3:00:00 PM |
HB 145 |
| HHSS HB 106 DPS Presentation 04.22.2021.pdf |
HHSS 4/22/2021 3:00:00 PM HHSS 5/13/2021 3:00:00 PM |
HB 106 |
| FHP Letter of Support for HB 145_4.20.2121.pdf |
HHSS 4/22/2021 3:00:00 PM |
HB 145 |
| HB 184 Powerpoint 4-22-21.pdf |
HHSS 4/22/2021 3:00:00 PM HTRB 5/4/2021 8:00:00 AM |
HB 184 |
| HB 184 Powerpoint 4-22-21.pptx |
HHSS 4/22/2021 3:00:00 PM |
HB 184 |